Phosphorylated tau targeted small-molecule PROTACs for the treatment of Alzheimer's disease and tauopathies - ScienceDirect
Proline Isomer-Specific Antibodies Reveal the Early Pathogenic Tau Conformation in Alzheimer's Disease - ScienceDirect
Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau | EMBO Molecular Medicine
Biomarkers for Alzheimer's disease: current status and prospects for the future - Blennow - 2018 - Journal of Internal Medicine - Wiley Online Library
Fluorescence Lifetime Imaging of p-tau Protein in Single Neuron with a Highly Selective Fluorescent Probe | Analytical Chemistry
Phospho-Tau (Thr205) Polyclonal Antibody (44-738G)
Norovirus P particle-based tau vaccine-generated phosphorylated tau antibodies markedly ameliorate tau pathology and improve behavioral deficits in mouse model of Alzheimer's disease | Signal Transduction and Targeted Therapy
Western blot (WB) analysis of phosphorylated (pTau) and total tau (Tau)... | Download Scientific Diagram
Clinical significance of fluid biomarkers in Alzheimer's Disease | SpringerLink
Frontiers | Hyperphosphorylation of Tau Associates With Changes in Its Function Beyond Microtubule Stability
Cholesteryl Esters Hobble Proteasomes, Increase p-Tau | ALZFORUM
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia | Nature Medicine
Phospho-Tau (Ser46) Antibody | Cell Signaling Technology
Co-localization of AD P-tau with normal tau and MAP2 in Noco/Tri cells.... | Download Scientific Diagram
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia | Nature Medicine
BBRC researchers identify new tau biomarkers to detect the preclinical phase of Alzheimer's disease | Barcelona Beta
P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles | Alzheimer's Research & Therapy | Full Text
Mechanism of psychoactive substance-induced cognitive disorders: does tau protein play a role?
Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology | SpringerLink
Disrupted ubiquitin proteasome system underlying tau accumulation in Alzheimer's disease - ScienceDirect
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease | Nature Communications
Synergistic Association between Plasma Aβ1–42 and p-tau in Alzheimer's Disease but Not in Parkinson's Disease or Frontotemporal Dementia | ACS Chemical Neuroscience
Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer's Disease | PLOS ONE
Cis P-tau in the CSF of severe TBI patients is neurotoxic and... | Download Scientific Diagram
Biomedicines | Free Full-Text | Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers
JCI - CHIP-ping away at tau
![Tau [p Thr181] Antibody (NB100-82245): Novus Biologicals](https://images.novusbio.com/images2/Tau-[p-Thr181]-Antibody-Western-Blot-NB100-82245-img0006.jpg "Tau [p Thr181] Antibody (NB100-82245): Novus Biologicals")
Tau [p Thr181] Antibody (NB100-82245): Novus Biologicals
Frontiers | Tau: A Signaling Hub Protein
